Peter E. Boyd - Net Worth and Insider Trading

Peter E. Boyd Net Worth

The estimated net worth of Peter E. Boyd is at least $209,553 dollars as of 2024-05-06. Peter E. Boyd is the SVP-Bus. Process & Info. Tech. of Aquestive Therapeutics Inc and owns about 59,532 shares of Aquestive Therapeutics Inc (AQST) stock worth over $209,553. Details can be seen in Peter E. Boyd's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter E. Boyd has not made any transactions after 2022-06-14 and currently still holds the listed stock(s).

Transaction Summary of Peter E. Boyd

To

Peter E. Boyd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter E. Boyd owns 1 companies in total, including Aquestive Therapeutics Inc (AQST) .

Click here to see the complete history of Peter E. Boyd’s form 4 insider trades.

Insider Ownership Summary of Peter E. Boyd

Ticker Comapny Transaction Date Type of Owner
AQST Aquestive Therapeutics Inc 2022-06-14 SVP-Operations/Value Delivery

Peter E. Boyd Latest Holdings Summary

Peter E. Boyd currently owns a total of 1 stock. Peter E. Boyd owns 59,532 shares of Aquestive Therapeutics Inc (AQST) as of June 14, 2022, with a value of $209,553.

Latest Holdings of Peter E. Boyd

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AQST Aquestive Therapeutics Inc 2022-06-14 59,532 3.52 209,553

Holding Weightings of Peter E. Boyd


Peter E. Boyd Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter E. Boyd has made a total of 4 transactions in Aquestive Therapeutics Inc (AQST) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Aquestive Therapeutics Inc is the acquisition of 5,000 shares on June 14, 2022, which cost Peter E. Boyd around $4,050.

Insider Trading History of Peter E. Boyd

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter E. Boyd Trading Performance

GuruFocus tracks the stock performance after each of Peter E. Boyd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter E. Boyd is 73.05%. GuruFocus also compares Peter E. Boyd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter E. Boyd within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Peter E. Boyd's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Peter E. Boyd

Average Return

Average return per transaction

Outperforming Transactions

4 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 14.96
Relative Return to S&P 500(%) 13.13

Peter E. Boyd Ownership Network

Ownership Network List of Peter E. Boyd

No Data

Ownership Network Relation of Peter E. Boyd


Peter E. Boyd Owned Company Details

What does Aquestive Therapeutics Inc do?

Who are the key executives at Aquestive Therapeutics Inc?

Peter E. Boyd is the SVP-Operations/Value Delivery of Aquestive Therapeutics Inc. Other key executives at Aquestive Therapeutics Inc include director & Chief Innovation/Tech Officer Alexander Mark Schobel , Chief Medical Officer Carl N Kraus , and SVP & Research & Development Stephen Wargacki .

Aquestive Therapeutics Inc (AQST) Insider Trades Summary

Over the past 18 months, Peter E. Boyd made no insider transaction in Aquestive Therapeutics Inc (AQST). Other recent insider transactions involving Aquestive Therapeutics Inc (AQST) include a net sale of 75,000 shares made by Alexander Mark Schobel ,

In summary, during the past 3 months, insiders sold 75,000 shares of Aquestive Therapeutics Inc (AQST) in total and bought 0 shares, with a net sale of 75,000 shares. During the past 18 months, 75,000 shares of Aquestive Therapeutics Inc (AQST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 75,000 shares.

Aquestive Therapeutics Inc (AQST)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aquestive Therapeutics Inc Insider Transactions

No Available Data

Peter E. Boyd Mailing Address

Above is the net worth, insider trading, and ownership report for Peter E. Boyd. You might contact Peter E. Boyd via mailing address: 30 Technology Drive, Warren Nj 07059.

Discussions on Peter E. Boyd

No discussions yet.